Navigation Links
Results of United Kingdom MRSA Surveillance Program Using Cepheid GeneXpert(R) System Demonstrate Benefits of Rapid Testing
Date:10/27/2008

SUNNYVALE, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today noted an announcement from Birmingham Children's Hospital highlighting results using Cepheid's Xpert(TM) MRSA test, which runs on the GeneXpert(R) System, to implement a screening program for all patients being admitted to its Intensive Care Unit (ICU).

The Birmingham Children's Hospital announcement, released yesterday, stated that "obtaining an accurate and rapid result for MRSA is absolutely key at the emergency admission point in hospitals. For example, if a patient is critically ill and needs to be admitted to the ICU without delay, clinicians simply cannot afford to wait two to three days for a culture result to see whether the patient has MRSA."

"It made sense to start the screening with ICU patients as they are the most susceptible to contracting the MRSA infection due to the bacteria most commonly gaining access to the body through open wounds, injections, catheters and IV sites," said Dr. Jim Gray, Consultant Microbiologist at Birmingham Children's Hospital. "It is vital to prevent MRSA from entering the ICU as it is extremely serious and potentially fatal for children who are already critically ill."

According to the announcement, Cepheid's Xpert(TM) MRSA test has proven to be 100 percent accurate, allowing doctors at the hospital to identify MRSA carriers in under an hour. To validate the 100 percent accuracy rate of the on-demand results obtained using Xpert MRSA, all results so far have been verified with a traditional culture-based test, which takes up to three days for results. The hospital has already identified cases of MRSA that they would normally not have discovered prior to patient admission.

"This is another excellent example demonstrating the growing recognition of rapid molecular-based testing as the basis for best practice surveillance programs," said Rob Koska, Cepheid's Senior Vice President of Worldwide Commercial Operatio
'/>"/>

SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Positive Study Results for Ceftaroline Phase III Clinical Study for the Treatment of Complicated Skin and Skin Structure Infections Presented at ICAAC / IDSA
2. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
3. Trubion Reports Re-treatment Results Following Phase 1/2a and Phase 2b Studies Evaluating TRU-015 for Rheumatoid Arthritis
4. China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries
5. BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza
6. Savient Pharmaceuticals to Hold Third Quarter 2008 Financial Results Conference Call on Thursday, November 6, 2008
7. BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008
8. Orchid Cellmark to Announce Third Quarter 2008 Financial Results on October 30, 2008
9. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
10. Anadys Pharmaceuticals Reports Third Quarter 2008 Financial Results and Highlights
11. Aware, Inc. Reports Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... 11 Gwathmey, Inc., a pre-clinical contract ... staph aureus, and cardiovascular disease announces a new ... that Rosalie Dunn, Ph.D., has joined Gwathmey as ... 28 years of experience working with small businesses ... Gwathmey, Dr. Dunn managed multimillion dollar portfolios for ...
(Date:12/10/2009)... -- Endologix, Inc. (Nasdaq: ELGX ), developer ... today that Dan Lemaitre, former President and CEO ... Directors effective December 11, 2009. Endologix now ... ,, Franklin D. Brown, Chairman of the Board, ... to the Endologix Board of Directors. He ...
(Date:12/10/2009)... provider of advanced flow measurement, control, and level ... company as Global Level Product Manager effective November ... to enhance market penetration of the level measurement ... Instrument from Lafarge Corp, a manufacturer of building ... and Sales. Bayda will report to Brooks Instrument ...
(Date:12/10/2009)... that it has entered into a multi-year, sole-source supply agreement ... the use of Martek’s products in Fonterra’s infant formulas and ... , ... Columbia, MD (Vocus) December 10, ... today that it has entered into a multi-year, sole-source supply ...
Breaking Biology Technology:Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Endologix Appoints Dan Lemaitre to its Board of Directors 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 2Brooks Instrument Appoints Mike Bayda as Global Level Product Manager 3Martek Signs Sole-Source Supply Agreement with Fonterra 2Martek Signs Sole-Source Supply Agreement with Fonterra 3
... CAMBRIDGE, Mass., July 2 Biopure Corporation,(Nasdaq: BPUR ... with,purchasers for a private placement of its common stock ... no exercise of the warrants. The,company intends to use ... The first closing occurred on June 30, 2008, and,subsequent ...
... Vice President, Marketing and Sales; Susan Koppy ... as Vice President, Corporate Development, PT. RICHMOND, Calif., July ... Moore to the position of,Vice President, Marketing and Sales and ... Mr. Moore and Ms. Koppy will report,to President & Chief ...
... 2 Pearl Therapeutics, Inc.,a biopharmaceutical company developing ... has completed the closing of an $18,million round ... extension to,its first venture financing, which closed in ... existing investors Clarus Ventures, New Leaf,Ventures, 5AM Ventures ...
Other Biology Technology:Biopure Announces Private Equity Financing 2Biopure Announces Private Equity Financing 3Transcept Pharmaceuticals Appoints Key Senior Executives 2Transcept Pharmaceuticals Appoints Key Senior Executives 3Transcept Pharmaceuticals Appoints Key Senior Executives 4Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors 2
(Date:12/14/2009)... date of the proteins in a species of salamander ... how similar regeneration could be induced in humans. ... University-Purdue University Indianapolis and colleagues investigated over three hundred ... of salamander that has the unique natural ability to ... hope that this knowledge will contribute to a better ...
(Date:12/14/2009)... once thought of tool use as a defining feature of ... other primates, along with birds and an array of other ... Current Biology , a Cell Press publication, adds an ... veined octopus under study manages a behavioral trick that the ... itself over stacked, upright coconut shell "bowls," makes its eight ...
(Date:12/14/2009)... As good as laparoscopy is in preventing some of the ... drawbacks, including reduced blood flow and organ dysfunction. Laparoscopy is ... incisions. , By adding another gas ... during laparoscopy, researchers at Duke University Medical Center have found ... , The gas ethyl nitrite (ENO) helped to open ...
Breaking Biology News(10 mins):IUPUI researchers tackle protein mechanisms behind limb regeneration 2Tool use in an invertebrate: The coconut-carrying octopus 2Gas improves blood flow and organ status during minimally invasive surgery 2Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 1Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 2Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 3Zogenix and Astellas Enter Exclusive Co Promotion Agreement in the US for Newly Approved Sumavel 28TM 29 DosePro 28TM 29 53474 4Cardinal Health Completes Biotech Acquisition 13325 1Cardinal Health Completes Biotech Acquisition 13325 2Vitamin D Deficiency Linked to Heart Risk Factors in Kids 53470 1Vitamin D Deficiency Linked to Heart Risk Factors in Kids 53470 2Vitamin D Deficiency Linked to Heart Risk Factors in Kids 53470 3
... release is available in French . ... the chilli cook-off, usually has a key secret ingredient, ... crucial proteins, which change the dynamics of cells from ... involving McGill University, the Research Institute of the McGill ...
... described the sudden origin of flowering plants about 130 million ... yet to solve. , But a new University of ... edition of the Proceedings of the National Academy of ... information about what the first flowers looked like and how ...
... hydrogen on an environmentally friendly and cost-effective basis by ... E.ON research award. , The new process of producing ... sunlight, biomass and water. It combines solar driven cleavage ... the use of energy derived from fossil fuels and ...
Other Biology News:Proteomics: Finding the key ingredients of disease 2University of Florida study provides insight into evolution of first flowers 2University of Florida study provides insight into evolution of first flowers 3Accolade for solar-hydrogen project 2
Multi-enzyme complex containing a wide range of carbohydrases, including arabanase, cellulase,b-glucanase, hemi-cellulase and xylanase Patent/trademark/license (electronic): A product of Novozyme Cor...
... Templates rich in GC content or ... difficult to amplify, and when subjected to ... Yield, specificity and consistency can be increased ... PCR amplification reactions. Polymer-Aide is an effective ...
... Application: The simple three step procedure (PCR, ... be completed in one day. The typical ... than 80%. , Features and Benefits: , ... cloned into any expression vector , High ...
Designed for use with all 96-well SPRI reagent kits. Used with round bottom 96-well microplates, and 96-well thermal cycling plates....
Biology Products: